Overview

Alzheimer's Disease: Therapeutic Potential of Estrogen

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a 15-month study to determine the effectiveness of hormone replacement therapy in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Institute on Aging (NIA)
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Medroxyprogesterone
Medroxyprogesterone Acetate
Polyestradiol phosphate
Progesterone